Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Injured in Rollover Crash on Highway 101 Near Valley Circle Boulevard


2 Vehicles Collide in Woodland Hills Accident

Woodland Hills, CA (April 4, 2020) – One person was injured in a rollover crash in Woodland Hills. The accident occurred on the evening of April 4 on Highway 101.

Two vehicles collided on southbound Highway 101, near Valley Circle Boulevard. The impact caused one to roll over. One person was hospitalized with serious injuries. 

#Woodland Hills

#91367


October 15, 2019

Woman Injured While Getting Gas on State Route 76

Cars Collide, Victim Goes Through Windshield in Oceanside Accident Oceanside, C...


March 16, 2020

1 Killed, 2 Injured in Crash on State Route 99 Near Hamilton Nord Cana Highway

2 Vehicles Collide Head-on in Fatal Chico Accident...


October 16, 2019

1 Killed in Crash on Highway 25 Near Bolsa Road

Cement Truck, Semi Truck Collide in Fatal Gilroy Accident Gilroy, CA (October 1...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.